Abstract

Ribavirin 40-mg/mL Suspension

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2007 - Hormone Replacement Therapy

Page(s): 334

Download in electronic PDF format for $75
  • Ribavirin 40-mg/mL Suspension Page 1

Abstract

A formulation for preparing Ribavirin 40-mg/mL Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • ribavirin
  • antiviral agent
  • formulation
  • viral infection
  • virus
  • acute respiratory syndrome

Related Categories

  • FORMULATIONS
  • INFECTIOUS DISEASE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2007
Pg. 334
Ribavirin 40-mg/mL Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2004
Pg. 486-488
Stability of Extemporaneous Oral Ribavirin Liquid Preparation
Author(s): Chan John P, Tong Henry H Y, Chow Alber H L
Nov/Dec 2016
Pg. 521-525
Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature
Author(s): Larson Bayli, Bushman Lane R, Casciano Matthew L, Oldland Alan R, Kiser Jennifer J, Kiser Tyree H
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Sep/Oct 2006
Pg. 324-328
Topical Cidofovir for Treatment of Resistant Viral Infections
Author(s): McElhiney Linda F
Mar/Apr 2010
Pg. 151
Acyclovir 200-mg/5-mL Oral Suspension (From the Injection)
Author(s): Allen Loyd V Jr
May/Jun 2010
Pg. 249
Voriconazole 40-mg/mL Oral Suspension, Veterinary
Author(s): Allen Loyd V Jr
Jan/Feb 2018
Pg. 59
Voriconazole 40-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2003
Pg. 132
Ribavirin 33-mg/mL Injection
Author(s): Allen Loyd V Jr
Jul/Aug 2012
Pg. 336
Foscarnet Sodium 24-mg/mL Injection
Author(s): Allen Loyd V Jr
Mar/Apr 2023
Pg. 98-107
Compounding for the Treatment of COVID-19 and Long COVID, Part 2: Manifestations of Infection, Nomenclature, Transmission, and Treatment
Author(s): Riepl Mike
Jul/Aug 2011
Pg. 342
Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2016
Pg. 510
Imatinib 40-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2021
Pg. 144
Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2003
Pg. 62
Ribavirin 200-mg Capsules
Author(s): Allen Loyd V Jr
Jan/Feb 2003
Pg. 10-15
View Sample
Compounding for the Effects of Weapons of Mass Destruction
Author(s): Sammarco Domenic A
Sep/Oct 2000
Pg. 334
Human Immunodeficiency Virus and the Acquired Immune Deficiency Syndrome
Author(s): Mathews Elizabeth
Sep/Oct 2010
Pg. 426
Rufinamide 40-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr